EU-trans Tasman bridge strengthened by UK's BIVDA (British In Vitro Diagnostics Association)
This article was originally published in Clinica
Executive Summary
As the new trans Tasman regulatory region gears up for major reforms that will see the first IVD-specific regulations for Australia and New Zealand, stronger links and synergies are developing with the diagnostics market of the EU. So said Doris-Ann Williams, director general of the British In Vitro Diagnostics Association (BIVDA), to Clinica, ahead of a regulatory meeting being hosted by the Medical Industry Association of New Zealand (MIANZ).